News

$3,770,000 of ALTRIA CLIENT SERVICES LLC lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"HJRes 59 and SJRes 25 A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Labor relating to "Adverse Effect Wage Rate Methodology for the Temporary Employment of H-2A Nonimmigrants in Non-Range Occupations in the United States"
Discussions concerning draft legislation to amend corporate tax rates Discussions concerning draft legislation on dividend tax rates Discussions regarding federal excise taxes on tobacco products Discussions concerning amendments to Section 958(b)(4) of the Internal Revenue Code Discussions concerning the full expensing of capital expenditures per the 2017 Tax Cuts & Jobs Act
HR 8752 Department of Homeland Security Appropriations Act, 2025; including enforcement efforts related to illegal e-cigarettes and other unauthorized tobacco products HR 9026/S 4795 Commerce, Justice, Science, and Related Agencies Appropriations Act, 2025: provisions related to enforcement efforts related to illegal e-cigarettes and other unauthorized tobacco products HR 9027/S 4690 Agriculture Rural Development Food and Drug Administration and Related Agencies Appropriations Act 2025; Section 733, provisions related to regulation of tobacco, including tobacco product standards and enforcement efforts related to illegal e-cigarettes and other unauthorized tobacco products HR 9029/S 4942 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025: provisions related to regulation of tobacco, including enforcement efforts related to illegal e-cigarettes and other unauthorized tobacco products
Discussions regarding the pending ITC final determination on Investigation No. 337-1368: Certain Vaporizer Devices, Cartridges Used Therewith, and Components Thereof
HR 901 Disposable ENDS Product Enforcement Act of 2023; all provisions of the bill HJRes 99 To amend the Federal Food Drug and Cosmetic Act to exempt the premium cigar industry from certain regulations; all provisions of the bill H. Res. 979 Expressing the sense of the House of Representatives that public health authorities and tobacco control advocates should encourage American innovation and embrace harm reduction as part of the comprehensive United States approach to tobacco control HR 1486 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2023; all provisions of the bill HR 8070/ S 4638 Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025; Section 1704, provisions related to enforcement efforts regarding illicit e-cigarettes and other unauthorized tobacco products HR 9425 Tobacco User Fee Modernization Act of 2024; all provisions of the bill S 464 No Tax Subsidies for E-Cigarette and Tobacco Ads Act; all provisions of the bill ANPRM for Docket No. FDA-2017-N-6189 Implementation of P.L. 111-31 Family Smoking Prevention and Tobacco Control Act Implementation of P.L. 117-103 Consolidated Appropriations Act, 2022; provisions related to providing FDA authority to regulate products containing synthetic nicotine Discussions related to tobacco harm reduction Discussions concerning proposals to ban characterizing flavors in tobacco products FDA-2021-N-1309, Proposed Rule regarding Tobacco Product Standard for Characterizing Flavors in Cigars FDA-2021-N-1349, Proposed Rule regarding Tobacco Product Standard for Menthol in Cigarettes Discussions regarding the FDAs need to urgently implement a compliance and enforcement plan to address and prohibit the importation and sale of illicit flavored, disposable electronic nicotine delivery system (ENDS) products Discussions concerning nicotine analogue products and FDAs regulatory authority over such products
HR 7979 End China's De Minimis Abuse Act; all provisions of the bill"

You can find more data on corporate lobbying on Quiver Quantitative.

MO Congressional Stock Trading

Members of Congress have traded $MO stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $MO stock by members of Congress over the last 6 months:

• REPRESENTATIVE PETE SESSIONS sold up to $15,000 on 09/10.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

MO Hedge Fund Activity

We have seen 889 institutional investors add shares of MO stock to their portfolio, and 848 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• BLACKROCK, INC. added 12,737,950 shares (+10.2%) to their portfolio in Q3 2024, for an estimated $650,144,968
• GOLDMAN SACHS GROUP INC removed 7,766,127 shares (-44.7%) from their portfolio in Q3 2024, for an estimated $396,383,122
• HARRIS ASSOCIATES L P removed 7,533,442 shares (-65.9%) from their portfolio in Q3 2024, for an estimated $384,506,879
• FMR LLC removed 6,344,519 shares (-54.4%) from their portfolio in Q3 2024, for an estimated $323,824,249
• ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 6,263,611 shares (+39.3%) to their portfolio in Q3 2024, for an estimated $319,694,705
• STATE STREET CORP added 3,910,738 shares (+5.6%) to their portfolio in Q3 2024, for an estimated $199,604,067
• BARCLAYS PLC added 3,117,753 shares (+80.0%) to their portfolio in Q3 2024, for an estimated $159,130,113

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

This article was originally published on Quiver News, read the full story.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.